Illumina logo

Illumina

North America, California, United States, San Diego

Description

Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.

Investor Profile

Illumina has made 20 investments, with 2 in the past 12 months and 20% as lead.

Stage Focus

  • Series A (20%)
  • Series Unknown (15%)
  • Series C (15%)
  • Seed (15%)
  • Pre Seed (10%)
  • Series B (5%)
  • Post Ipo Equity (5%)
  • Corporate Round (5%)
  • Series F (5%)
  • Series D (5%)

Country Focus

  • United States (65%)
  • United Kingdom (25%)
  • Canada (10%)

Industry Focus

  • Biotechnology
  • Health Care
  • Health Diagnostics
  • Genetics
  • Biopharma
  • Medical
  • Bioinformatics
  • Personal Health
  • Life Science
  • Nanotechnology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Illumina frequently co-invest with?

Lansdowne Partners
Europe, England, United Kingdom, London
Co-Investments: 2
Sutter Hill Ventures
North America, California, United States, Palo Alto
Co-Investments: 4
Kleiner Perkins
North America, California, United States, Menlo Park
Co-Investments: 2
Mayo Clinic
North America, Minnesota, United States, Rochester
Co-Investments: 3
Warburg Pincus
Europe, Madrid, Spain, Boadilla Del Monte
Co-Investments: 3
OS Fund
North America, Illinois, United States, Chicago
Co-Investments: 2
Invesco
North America, Georgia, United States, Atlanta
Co-Investments: 2
Viking Global Investors
North America, Connecticut, United States, Stamford
Co-Investments: 4
IP Group
Europe, England, United Kingdom, London
Co-Investments: 2
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 2

Which angels does Illumina often collaborate with?

Daniel Curran
North America, California, United States, Santa Monica
Shared Deals: 1
JP
North America, California, United States, San Francisco
Shared Deals: 1
BG
North America, Washington, United States, Seattle
Shared Deals: 1
Tan Thay
Asia, Kuala Lumpur, Malaysia, Kuala Lumpur
Shared Deals: 1
AN
North America, Massachusetts, United States, Cambridge
Shared Deals: 1
NH
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Illumina?

Truveta

Bellevue, Washington, United States

Truveta is a healthcare data platform that provides EHR data for scientific research.

AnalyticsData ManagementHealth Care
Series CJan 13, 2025
Amount Raised: $320,000,000
Cache

Foster City, California, United States

Cache is advancing personalized medicine and digital data storage by making storage and access to biomolecules widely accessible.

BiopharmaBiotechnologyInformation TechnologyPrecision Medicine
SeedMay 7, 2024
Mantra Bio

San Francisco, California, United States

Mantra Bio is the creator of REVEAL, an exosome engineering platform combining computational biology and lab automation.

BiotechnologyLife Science
Series AJan 4, 2023
Amount Raised: $9,000,000
Mable (Neurolytic Healthcare)

Oxford, Oxfordshire, United Kingdom

Genomics based individualized care for people with neurological conditions.

Health CareMedicalNeuroscience
Pre SeedJul 27, 2022
SomaLogic

Boulder, Colorado, United States

SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.

BiotechnologyHealth CareHealth DiagnosticsMedical Device
Post Ipo EquitySep 1, 2021
Amount Raised: $375,000,000
Concr

London, England, United Kingdom

Astrophysics technology for precision therapy through accurate modelling of biology

BiopharmaBiotechnologyMachine Learning
Pre SeedApr 1, 2021
Amount Raised: $691,491
Ginkgo Bioworks

Boston, Massachusetts, United States

Ginkgo Bioworks is a developer of biological engineering products and custom microbes across multiple markets.

BiopharmaBiotechnologyChemical
Series FMay 28, 2020
Amount Raised: $70,000,000
Helix

San Mateo, California, United States

Helix is a population genomics company that is working to advance genomics research and integrate genomic data into clinical care.

Big DataBioinformaticsBiotechnologyBlockchainCryptocurrencyFinTechGeneticsHealth CarePersonal Health
Series BMar 1, 2018
Amount Raised: $200,000,000
Helixis

Carlsbad, California, United States

Helixis, Inc. is a company that develops low-cost molecular diagnostic products.

BiotechnologyHealth DiagnosticsMedical
Series UnknownMar 1, 2018
Amount Raised: $200,000,000
Prospect Bio

Brisbane, California, United States

Prospect Bio is a synthetic biology company that specializes in building biosensors (living cells) that can measure chemicals.

BioinformaticsBiotechnologyNeuroscience
SeedNov 15, 2016
Amount Raised: $2,800,000